These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18534360)

  • 21. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    ; Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; ; Epstein AE; DiMarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; ; Anderson JL; Jacobs AK; Halperin JL; Albert NM; Creager MA; DeMets D; Ettinger SM; Guyton RA; Hochman JS; Kushner FG; Ohman EM; Stevenson W; Yancy CW; ; ; ; ;
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):e127-45. PubMed ID: 23140976
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac pacing: the state of the art.
    Trohman RG; Kim MH; Pinski SL
    Lancet; 2004 Nov 6-12; 364(9446):1701-19. PubMed ID: 15530632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).
    Khairy P; Van Hare GF; Balaji S; Berul CI; Cecchin F; Cohen MI; Daniels CJ; Deal BJ; Dearani JA; Groot Nd; Dubin AM; Harris L; Janousek J; Kanter RJ; Karpawich PP; Perry JC; Seslar SP; Shah MJ; Silka MJ; Triedman JK; Walsh EP; Warnes CA
    Can J Cardiol; 2014 Oct; 30(10):e1-e63. PubMed ID: 25262867
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging indications for cardiac pacing.
    Slotwiner DJ; Stein KM; Markowitz SM; Mittal S; Iwai S; Das M; Lerman BB
    Heart Dis; 2001; 3(4):224-30. PubMed ID: 11975798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualizing decisions for patients with prophylactic implantable cardiac defibrillators subject to device advisories: a commentary.
    Bigger JT; Kleiger RE
    Am J Cardiol; 2006 Nov; 98(9):1291-3. PubMed ID: 17056349
    [No Abstract]   [Full Text] [Related]  

  • 27. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS).
    Boriani G; Fauchier L; Aguinaga L; Beattie JM; Blomstrom Lundqvist C; Cohen A; Dan GA; Genovesi S; Israel C; Joung B; Kalarus Z; Lampert R; Malavasi VL; Mansourati J; Mont L; Potpara T; Thornton A; Lip GYH;
    Europace; 2019 Jan; 21(1):7-8. PubMed ID: 29905786
    [No Abstract]   [Full Text] [Related]  

  • 28. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
    Epstein AE; DiMarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; ; ;
    J Am Coll Cardiol; 2013 Jan; 61(3):e6-75. PubMed ID: 23265327
    [No Abstract]   [Full Text] [Related]  

  • 29. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
    Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The guidelines of the ANMCO-SIC-AIAC on the appropriate use of the methods of permanent cardiac electric stimulation. Associazione Nazionale Medici Cardiologi Ospedalieri-Società Italiana di Cardiologia-Associazione Italiana di Aritmologia e Cardiostimolazione].
    Zoni Berisso M; Bongiorni MG; Della Bella P; Proclemer A; Viani S
    Ital Heart J Suppl; 2000 Apr; 1(4):551-68. PubMed ID: 10832144
    [No Abstract]   [Full Text] [Related]  

  • 32. A premature low-birth-weight infant with congenital complete atrioventricular block and myocarditis successfully treated by staged pacemaker implantation.
    Fujioka T; Nii M; Tanaka Y
    Cardiol Young; 2016 Jun; 26(5):1029-32. PubMed ID: 27071550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Latest results of treatment with pacemaker and implantable cardioverter defibrillators].
    Merkely B
    Orv Hetil; 2005 May; 146(20 Suppl 2):1088-98. PubMed ID: 15945237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for pacemaker programming in acute heart failure.
    Lahiri MK; Mao JT; Schuger CD
    Heart Fail Rev; 2011 Sep; 16(5):441-8. PubMed ID: 21400230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of expanding indications on the safety of pacemakers and defibrillators.
    Maisel WH; ; ;
    Card Electrophysiol Rev; 2003 Jan; 7(1):30-2. PubMed ID: 12766513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender differences and demographics and type of cardiac device over a 10-year period.
    Aktoz M; Uçar MF; Yılmaztepe MA; Taylan G; Altay S
    Niger J Clin Pract; 2018 Jan; 21(1):27-32. PubMed ID: 29411719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of ventricular pacing: where should we implant the leads?
    Gold MR
    J Am Coll Cardiol; 1999 Feb; 33(2):324-6. PubMed ID: 9973010
    [No Abstract]   [Full Text] [Related]  

  • 38. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.
    Vardas PE; Auricchio A; Blanc JJ; Daubert JC; Drexler H; Ector H; Gasparini M; Linde C; Morgado FB; Oto A; Sutton R; Trusz-Gluza M; ;
    Eur Heart J; 2007 Sep; 28(18):2256-95. PubMed ID: 17726042
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolving indications for permanent pacing.
    Hayes DL
    Am J Cardiol; 1999 Mar; 83(5B):161D-165D. PubMed ID: 10089860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrical therapy for heart failure: evolving indications and choices.
    Wilkoff BL
    Tex Heart Inst J; 2005; 32(2):212-4. PubMed ID: 16107118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.